Analyst Price Targets — ATAI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 27, 2026 8:52 am | — | Deutsche Bank | $12.00 | $3.35 | TheFly | AtaiBeckley initiated with a Buy at Deutsche Bank |
| March 6, 2026 8:37 pm | Andrew Tsai | Jefferies | $10.00 | $3.39 | StreetInsider | Jefferies Reiterates Buy Rating on atai Life Sciences N.V (ATAI): "keen on ATAI's robust BPL-003 Phase IIb TRD results" |
| January 20, 2026 11:50 am | — | Guggenheim | $11.00 | $3.64 | TheFly | Atai Beckley initiated with a Buy at Guggenheim |
| October 22, 2025 10:31 am | — | Canaccord Genuity | $14.00 | $5.87 | TheFly | Atai Life Sciences price target raised to $14 from $11 at Canaccord |
| October 13, 2025 9:51 am | — | Needham | $12.00 | $5.10 | TheFly | Atai Life Sciences initiated with a Buy at Needham |
| May 20, 2025 4:09 pm | Andrew Tsai | Jefferies | $5.00 | $2.05 | TheFly | Phase 2a data for BPL-003 'encouraging' for Atai Life Sciences, says Jefferies |
| April 3, 2024 7:58 am | Jason McCarthy | Maxim Group | $6.00 | $1.87 | StreetInsider | Maxim Group Upgrades atai Life Sciences N.V (ATAI) to Buy |
Latest News for ATAI
Silverbullet Data Services Group PLC (LSE:SBDS) saw its shares rise 10.5%, to 21p, after revealing its first period of positive EBITDA, in the first quarter...
Johnson & Johnson (NYSE:JNJ)'s Spravato is reinforcing investor interest in the broader psychedelics sector as it reported another quarter of strong sales growth, with Jefferies analysts pointing to implications for companies such as AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) and peers developing next-generation mental health treatments. Spravato (esketamine nasal spray), which is approved for treatment-resistant…
Johnson & Johnson (NYSE:JNJ)’s Spravato is reinforcing investor interest in the broader psychedelics sector as it reported another quarter of strong sales...
Dr. Srinivas Rao, Co-Founder and Chief Executive Officer of AtaiBeckley, will participate in the 25th Annual Needham Virtual Healthcare Conference (April 13 - 16) and the Needham Virtual Psychedelics Forum (April 27) Dr. Srinivas Rao, Co-Founder and Chief Executive Officer of AtaiBeckley, will participate in the 25th Annual Needham Virtual Healthcare Conference (April 13 - 16) and the Needham Virtual Psychedelics…
Ceres Power Holdings PLC (LSE:CWR, OTC:CPWHF) fell 7% to 320p on Thursday after Peel Hunt downgraded the fuel cell technology developer to 'sell' from...
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ATAI.
U.S. House Trading
No House trades found for ATAI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.